Traditional Acupuncture in Migraine: A Controlled, Randomized Study
Facco et al. · Headache · 2008
Evidence Level
STRONGOBJECTIVE
To assess the efficacy of traditional Chinese acupuncture in the prevention of migraine without aura
WHO
160 patients with migraine without aura (3-8 attacks per month)
DURATION
6 months of follow-up with assessments at 3 and 6 months
POINTS
Individualized point selection based on TCM syndrome differentiation (7 different protocols)
🔬 Study Design
True Acupuncture
n=32
TCM-based acupuncture + rizatriptan
Ritualized Sham Acupuncture
n=30
Sham acupuncture with TCM ritual + rizatriptan
Standard Sham Acupuncture
n=31
Standard sham acupuncture + rizatriptan
Control
n=34
Rizatriptan only
📊 Results in numbers
MIDAS reduction - True Acupuncture T1
MIDAS reduction - True Acupuncture T2
Reduction in rizatriptan use - TA group
Statistical significance vs control
📊 Outcome Comparison
MIDAS index at 6 months
This study showed that traditional Chinese acupuncture, when applied following the principles of Chinese medicine, can be highly effective in preventing migraine. Patients who received true acupuncture experienced lasting improvement, with significant reduction in attacks and lower need for rescue medication.
Article summary
Plain-language narrative summary
Headache represents a significant public health problem, affecting an important portion of working-age adults and causing major day-to-day limitations. Migraine, in particular, affects a large number of people and, despite advances in pharmacologic treatment, many patients are unable to adequately control their symptoms or face undesirable side effects. As a result, there is growing interest in alternative treatments, including acupuncture. Studies show that approximately 19% of headache patients use acupuncture and consider it the most effective non-conventional treatment.
In the specific case of migraine, about 12% of patients have already tried acupuncture and 73% would be willing to try this treatment. Although several scientific reviews indicate the potential of acupuncture in migraine prevention, the evidence is still considered weak, mainly due to the wide variability in study methods used across different research.
The researchers conducted a randomized, controlled trial aimed at assessing the efficacy of traditional Chinese acupuncture in the treatment of migraine without aura, comparing it with different types of placebo treatments and untreated controls. The study included 160 patients diagnosed with migraine without aura who had between 3 and 8 attacks per month and had tried at least one previous preventive treatment without success. Participants were randomly divided into four groups: true acupuncture based on traditional Chinese medicine plus rescue medication (rizatriptan), ritualized sham acupuncture plus medication, standard sham acupuncture plus medication, and rescue medication only. The methodology included evaluating patients according to the principles of traditional Chinese medicine, selecting specific acupuncture points for the different syndromes identified.
Treatments were performed twice a week in two courses of 10 sessions each, with a one-week interval. To measure outcomes, the MIDAS questionnaire was used—a validated tool that assesses the degree of disability caused by headache—administered before treatment and after 3 and 6 months.
Of the 160 patients initially enrolled, 127 completed the study. Results showed that all groups improved relative to baseline, but only the true acupuncture group maintained consistent and lasting benefits over the six months of follow-up. The true acupuncture group showed significant reduction both in the disability index (from 22.2 to approximately 2.2 points) and in the use of rescue medication. The ritualized sham acupuncture group showed only temporary improvement at 3 months, returning to previous levels at 6 months, suggesting a transient placebo effect.
The other groups did not show significant improvements beyond those explainable by the use of rescue medication. Interestingly, the study also verified that the consumption of rescue medication tracked the disability questionnaire results in all groups, being lowest in the true acupuncture group.
For patients suffering from migraine, these results suggest that traditional Chinese acupuncture may be an effective option for prevention, providing reduction both in the frequency and intensity of attacks and in the need for medication. The study is particularly relevant because it used an authentically TCM-based approach, including specific diagnosis and individualized acupuncture point selection according to the different types of syndromes identified. For health professionals, the findings indicate the importance of properly applying traditional acupuncture principles, suggesting that efficacy may depend significantly on appropriate point selection and correct evaluation according to Chinese medicine criteria. The transient placebo effect observed in the ritualized sham acupuncture group also highlights the importance of the therapeutic relationship and the ritual of care in traditional medicine.
The study has some limitations that should be considered when interpreting the results. First, there was a considerable dropout rate (33 of 160 participants), which may influence the generalizability of the findings. In addition, the researchers did not administer questionnaires to assess whether patients could distinguish between true and sham acupuncture, which could help better understand the role of placebo effect. Patient classification according to traditional Chinese medicine also varies between different texts and schools, which may affect study reproducibility.
The authors acknowledge that this represents a first effort to appropriately combine the principles of Western medicine and traditional Chinese medicine in acupuncture research. Despite these limitations, the study represents an important advance in the scientific validation of acupuncture for migraine, providing evidence that the correct application of traditional principles can result in significant and lasting clinical benefits for patients.
Strengths
- 1First rigorous application of TCM principles in Western research
- 2Multiple control groups including a sophisticated placebo
- 3Long-term follow-up (6 months)
- 4Individualized point selection based on syndrome differentiation
Limitations
- 1Lack of post-treatment questionnaire to assess credibility
- 2Variability in TCM classification across different texts
- 320.6% dropout rate over the course of the study
- 4Lack of data on patients' prior rescue therapy
Expert Commentary
Dr. Marcus Yu Bin Pai
MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
▸ Clinical Relevance
Migraine without aura refractory to at least one preventive—exactly the profile recruited here—is the clinical scenario in which medical acupuncture finds its most solid indication in the pain clinic. The central finding of this work by Facco et al. is that TCM acupuncture, combined with rizatriptan as rescue, reduced the MIDAS score from 22.2 to about 2.2 points, with sustained effect at six months and reduced triptan consumption from 10.0 to 4.2 tablets per month. In practice, this means we can integrate acupuncture into the therapeutic plan of patients who did not tolerate or respond to beta-blockers, topiramate, or amitriptyline, without giving up rescue pharmacotherapy. Populations with comorbidities that limit the use of oral preventives—patients with cardiac disease, those with overweight and metabolic risk, or pregnant women in the second trimester—particularly benefit from this combined strategy.
▸ Notable Findings
The most noteworthy aspect is not the efficacy of acupuncture itself, but the differential time course between the groups. The ritualized sham acupuncture group—which included the same diagnostic ritual and the same therapist-patient relationship—showed significant improvement at three months, but with return to baseline values at six months. True acupuncture, on the other hand, maintained the benefits at T2 with scores virtually identical to those at T1 (2.1 vs 2.2). This temporal dissociation between placebo effect and specific effect is rare in acupuncture studies and substantially strengthens the argument that individualized point selection according to syndromic diagnosis produces a distinct and sustained neurobiological effect. The parallel between MIDAS reduction and rizatriptan consumption reduction in all groups reinforces the validity of MIDAS as a sensitive functional outcome in this context.
▸ From My Experience
In my practice in the pain and rehabilitation clinic, I have observed that patients with high-frequency episodic migraine—four to six attacks per month—usually present the first perceptible responses between the fourth and sixth session, generally reporting reduction in intensity before reduction in frequency. The protocol I usually adopt involves two courses of ten sessions with a one-week interval, exactly as described in this work, followed by monthly maintenance for six to twelve months depending on clinical stability. The profile that responds best in the office is the female patient between 30 and 50 years of age, with predominantly unilateral headache, marked photophobia, and a history of poor response or intolerance to conventional preventives. I systematically combine acupuncture with sleep hygiene and trigger control, and when there is an associated cervical component, I integrate dry needling of suboccipital trigger points into the protocol. The reduction in triptan consumption observed in this study is consistent with what I see routinely and has relevant practical impact in preventing medication overuse.
Full original article
Read the full scientific study
Headache · 2008
DOI: 10.1111/j.1526-4610.2007.00916.x
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories